Roche proposes novel pricing plan for new drugs
The manufacturer's proposed model is similar to that used in other European countries, where patients get access to new medicines while prices are being negotiated
Roche, a major global pharmaceutical manufacturer, has urged the government to pilot a new payment model that would enable patients in Ireland to get early access to innovative new drugs.
Roche’s proposed model is similar to that used in other European countries, where patients get access to new medicines while prices are being negotiated.
Roche has a new medicine called Ocrelizumab (trade name Ocrevus), which was recently approved by the European Medicines Agency....
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Ireland’s medicinal cannabis scheme needs overhaul, advocate says
Prohibition Partners says patients are being done a ‘disservice’ while state is losing out on economic benefits of an industry predicted to be worth €3.2 billion by 2025
Some people with cystic fibrosis still awaiting Covid-19 vaccine, charity warns
Cystic Fibrosis Ireland expresses concern about younger patients who are at very high risk from the coronavirus but still have not received their jab
Top medic: ‘If the state can pay for Viagra, it can pay for extreme pregnancy sickness drugs’
Peter Boylan, a former master of the National Maternity Hospital, says hyperemesis gravidarum is a severe condition and it‘s reasonable to expect the drugs payment scheme to reimburse sufferers
Over 300 administered vaccine doses not recorded as given to priority groups
HSE says failure to record cohort of vaccine recipient may be due to poor record keeping or a technical issue
